SG Americas Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.2M Sell
818,912
-1,246,365
-60% -$83M 0.03% 333
2026
Q1
$130M Buy
2,065,277
+1,524,219
+282% +$106M 0.14% 123
2025
Q4
$35.9M Buy
541,058
+393,316
+266% +$25.4M 0.05% 303
2025
Q3
$9.94M Buy
147,742
+121,566
+464% +$9.62M 0.03% 326
2025
Q2
$2.29M Buy
26,176
+9,079
+53% +$712K 0.01% 716
2025
Q1
$1.17M Buy
17,097
+11,273
+194% +$920K ﹤0.01% 1063
2024
Q4
$453K Sell
5,824
-65,199
-92% -$4.83M ﹤0.01% 1419
2024
Q3
$4.76M Buy
71,023
+24,442
+52% +$2.01M 0.02% 428
2024
Q2
$5.28M Sell
46,581
-31,345
-40% -$3.96M 0.03% 524
2024
Q1
$10.8M Buy
77,926
+34,901
+81% +$4.39M 0.05% 346
2023
Q4
$5.34M Sell
43,025
-4,422
-9% -$452K 0.05% 343
2023
Q3
$4.43M Buy
47,447
+8,100
+21% +$913K 0.05% 339
2023
Q2
$5.06M Buy
39,347
+10,744
+38% +$1.3M 0.04% 368
2023
Q1
$3.32M Sell
28,603
-66,454
-70% -$7.44M 0.04% 425
2022
Q4
$10.8M Buy
95,057
+31,726
+50% +$3.48M 0.13% 134
2022
Q3
$5.1M Sell
63,331
-9,780
-13% -$828K 0.06% 257
2022
Q2
$5.45M Buy
73,111
+51,675
+241% +$4.72M 0.06% 277
2022
Q1
$2.74M Sell
21,436
-9,040
-30% -$989K 0.02% 706
2021
Q4
$4.09M Buy
30,476
+12,444
+69% +$1.79M 0.02% 592
2021
Q3
$2.46M Sell
18,032
-18,276
-50% -$2.3M 0.01% 1083
2021
Q2
$3.88M Sell
36,308
-16,904
-32% -$1.62M 0.02% 729
2021
Q1
$4.78M Buy
53,212
+13,736
+35% +$1.29M 0.03% 534
2020
Q4
$3.65M Buy
39,476
+10,764
+37% +$961K 0.02% 695
2020
Q3
$2.96M Sell
28,712
-37,324
-57% -$3.9M 0.02% 543
2020
Q2
$6.69M Buy
66,036
+58,848
+819% +$5.26M 0.06% 258
2020
Q1
$484K Buy
+7,188
New +$447K ﹤0.01% 1865
2019
Q4
Sell
-20,352
Closed -$965K 3315
2019
Q3
$759K Sell
20,352
-17,648
-46% -$686K 0.01% 1594
2019
Q2
$1.42M Sell
38,000
-43,968
-54% -$1.38M 0.01% 1224
2019
Q1
$2.44M Buy
81,968
+76,460
+1,388% +$2.69M 0.02% 743
2018
Q4
$165K Sell
5,508
-24,912
-82% -$790K ﹤0.01% 2483
2018
Q3
$1.09M Buy
30,420
+5,232
+21% +$162K 0.01% 1624
2018
Q2
$598K Buy
25,188
+15,768
+167% +$334K 0.01% 1873
2018
Q1
$175K Buy
+9,420
New +$139K ﹤0.01% 2515
2017
Q2
Sell
-34,228
Closed -$725K 3250
2017
Q1
$725K Buy
34,228
+6,916
+25% +$135K 0.01% 1596
2016
Q4
$408K Buy
+27,312
New +$484K ﹤0.01% 1835
2015
Q4
Sell
-24,528
Closed -$526K 2756
2015
Q3
$526K Buy
24,528
+16,528
+207% +$369K ﹤0.01% 1049
2015
Q2
$160K Buy
8,000
+1,428
+22% +$25.1K ﹤0.01% 2085
2015
Q1
$102K Sell
6,572
-31,248
-83% -$472K ﹤0.01% 2275
2014
Q4
$520K Buy
37,820
+8,368
+28% +$102K ﹤0.01% 1626
2014
Q3
$294K Buy
29,452
+12,576
+75% +$129K ﹤0.01% 1775
2014
Q2
$167K Buy
16,876
+820
+5% +$7.27K ﹤0.01% 2128
2014
Q1
$166K Buy
+16,056
New +$166K ﹤0.01% 2015
2013
Q4
Sell
-50,524
Closed -$357K 2716
2013
Q3
$357K Buy
+50,524
New +$320K ﹤0.01% 1808

Other funds holding DXCM

SG Americas Securities's DXCM Position: Q2 2026 in Review

SG Americas Securities reduced its DexCom (DXCM) stake by 60% in Q2 2026, selling an estimated $83M and leaving 818,912 shares worth $55.2M. The position accounts for 0.03% of the portfolio, ranked #333.

SG Americas Securities first reported a position in DXCM in Q3 2013 and has held it in 43 quarters since. The position peaked at $130M in Q1 2026. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • SG Americas Securities held 818,912 shares of DexCom worth $55.2M as of Q2 2026.
  • SG Americas Securities sold 1,246,365 DexCom shares in Q2 2026, an estimated $83M.
  • DexCom made up 0.03% of SG Americas Securities's portfolio in Q2 2026, its #333 holding.
  • SG Americas Securities first reported a position in DexCom in Q3 2013 and has held it in 43 quarters since.
  • SG Americas Securities's DexCom position peaked at $130M in Q1 2026.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.